🚨ICYMI: Cochrane #HTN Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WLwgI
In ppl w/ mildly elevated #BloodPressure (BP) w/out CVD or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview#MedEd
🚨ICYMI: Cochrane #HTN Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WLwgI
In ppl w/ mildly elevated #BloodPressure (BP) w/out CVD or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview#MedEd
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
https://t.co/r8ZiKbCIdS
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence#bloodpressure#deprescribing
🚨ICYMI: Cochrane #HTN Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WM46g
In ppl w/ mildly elevated #BloodPressure (BP) w/out CVD or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview#MedEd
🚨ICYMI: Cochrane #HTN Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WLwgI
In ppl w/ mildly elevated #BloodPressure (BP) w/out CVD or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview#MedEd
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
https://t.co/r8ZiKbCaok
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence#bloodpressure#deprescribing
ICYMI- UPDATED review: Long‐term effects of weight‐reducing drugs in people with #hypertension
https://t.co/1SCOZCmgVL
👉🏼 8 RCTs, 13,000+ people
👉🏼Evidence for people w/ HTN insufficient re: benefit of pharmacological weight loss on risk of mortality or cardiovascular morbidity
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
https://t.co/r8ZiKbCIdS
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence#bloodpressure#deprescribing
🚨ICYMI: Cochrane Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WM46g
In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview
🚨ICYMI: Cochrane #HTN Review update
Pharmacotherapy for mild #hypertension https://t.co/n62k0WM46g
In ppl w/ mildly elevated #BloodPressure (BP) w/out CVD or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview#MedEd
ICYMI: Long‐term effects of weight‐reducing drugs in people with #hypertension
https://t.co/1SCOZClJ6d
👉🏼 8 RCTs, 13,000+ people
👉🏼Evidence for people w/ HTN insufficient regarding benefits of pharmacological weight loss on risk of mortality or cardiovascular morbidity
🆕 POSTDOCTORAL RESEARCH FELLOW 🆕
The Therapeutics Initiative at UBC seeks a full-time postdoctoral fellow for an initial appointment of 1 year with the possibility of renewal
Details + application link:
https://t.co/AIM4Nh5WtA
#JoinUs#Postdoctoraljobs#ResearchJobs
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
https://t.co/r8ZiKbCIdS
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence#bloodpressure#deprescribing